Skip to content
OpenCapital
Get started

CNO Financial Group CNO Supplemental health — Issuances

Other product segments

Medicare supplement
$275M+74.7%
Traditional life
$90.3M-1.8%
Long-term care
$45.3M+5.1%

Other financials

Income statement

See full
Revenue$1.0B+2.5%
Net income$37.7M+75.3%
EPS (diluted)$0.39+85.7%

Balance sheet

See full
Cash & equivalents$1.2B+12.6%
Total debt$1.4B-41.0%
Total equity$2.5B-2.2%
Total assets$39.0B+4.1%

Cash flow

See full
Operating cash flow$148.8M+8.9%

Valuation

See full
Market cap$4.93B-7.9%

Profitability

See full
Net margin5.4%-2.2pp

Returns & leverage

See full
Return on equity9.7%-3.7pp
Debt / equity0.5×-0.4×

Where this comes from

Reported directly by CNO Financial Group in its filing.

Tagged under the XBRL concept us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance.

The official record: CNO Financial Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CNO Financial Group's supplemental health — issuances.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CNO Financial Group's supplemental health — issuances?
CNO Financial Group (CNO) reported supplemental health — issuances of $63.8M in Q1 2026.
How has CNO Financial Group's supplemental health — issuances changed year-over-year?
CNO Financial Group's supplemental health — issuances decreased by 42.6% year-over-year, from $111.2M to $63.8M.
What is the long-term trend for CNO Financial Group's supplemental health — issuances?
Over 3 years (2022 to 2025), CNO Financial Group's supplemental health — issuances has grown at a -0.4% compound annual growth rate (CAGR), from $299.1M to $295.7M.
What does supplemental health — issuances mean?
This metric tracks the total value or volume of new supplemental health insurance policies issued during a specific period. It serves as a primary indicator of sales momentum and market penetration within the target demographic. Growth in issuances reflects the effectiveness of the company's distribution channels and product appeal.